Brief: Ashington Innovation Continues To Pursue Negotiations To Acquire Cell Therapy

Ashington Innovation

05/09/2023 07:33

Sept 5 (Reuters) - Ashington Innovation PLC  ASHI.L :
    * UPDATE ON CELL THERAPY AND CALON DISCUSSIONS
    * CONTINUES TO PURSUE NEGOTIATIONS TO ACQUIRE CELL THERAPY
LIMITED
AND CALON CARDIO-TECHNOLOGY LIMITED
    * PROPOSED ACQUISITION OF CALON IS DEPENDENT ON A SUCCESSFUL
CLOSE
OF CELL THERAPY TRANSACTION
    * FOLLOWING A BREACH OF CONFIDENTIALITY BY ITS BROKER, SI
CAPITAL,
APPOINTMENT OF SI CAPITAL HAS BEEN TERMINATED
    * SEEKING TO APPOINT A NEW SOLE BROKER

Source text for Eikon:  ID:nRSE3475La 
Further company coverage:  ASHI.L 

 ((Reuters.Briefs@thomsonreuters.com;;))